Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. DLG4-related synaptopathy: a new rare brain disorder

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. NEXMIF encephalopathy: an X-linked disorder with male and female phenotypic patterns

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. DOORS syndrome and a recurrent truncating ATP6V1B2 variant

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Prevalence of Pathogenic Germline DICER1 Variants in Young Individuals Thyroidectomised Due to Goitre - A National Danish Cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Cohort profile and heritability assessment of familial pancreatic cancer: a nation-wide study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • GEMO Study Collaborators
Vis graf over relationer

PURPOSE: We assessed the associations between population-based polygenic risk scores (PRS) for breast (BC) or epithelial ovarian cancer (EOC) with cancer risks for BRCA1 and BRCA2 pathogenic variant carriers.

METHODS: Retrospective cohort data on 18,935 BRCA1 and 12,339 BRCA2 female pathogenic variant carriers of European ancestry were available. Three versions of a 313 single-nucleotide polymorphism (SNP) BC PRS were evaluated based on whether they predict overall, estrogen receptor (ER)-negative, or ER-positive BC, and two PRS for overall or high-grade serous EOC. Associations were validated in a prospective cohort.

RESULTS: The ER-negative PRS showed the strongest association with BC risk for BRCA1 carriers (hazard ratio [HR] per standard deviation = 1.29 [95% CI 1.25-1.33], P = 3×10-72). For BRCA2, the strongest association was with overall BC PRS (HR = 1.31 [95% CI 1.27-1.36], P = 7×10-50). HR estimates decreased significantly with age and there was evidence for differences in associations by predicted variant effects on protein expression. The HR estimates were smaller than general population estimates. The high-grade serous PRS yielded the strongest associations with EOC risk for BRCA1 (HR = 1.32 [95% CI 1.25-1.40], P = 3×10-22) and BRCA2 (HR = 1.44 [95% CI 1.30-1.60], P = 4×10-12) carriers. The associations in the prospective cohort were similar.

CONCLUSION: Population-based PRS are strongly associated with BC and EOC risks for BRCA1/2 carriers and predict substantial absolute risk differences for women at PRS distribution extremes.

OriginalsprogEngelsk
TidsskriftGenetics in medicine : official journal of the American College of Medical Genetics
Vol/bind22
Udgave nummer10
Sider (fra-til)1653-1666
Antal sider14
ISSN1098-3600
DOI
StatusUdgivet - okt. 2020

ID: 61369930